Saskatchewan patients with specific cancers can now receive an innovative type of immunotherapy closer to home. The Saskatchewan Cancer Agency (Cancer Agency), along with the Saskatchewan Health Authority (SHA), is launching the revolutionary Chimeric Antigen Receptor T-cell (CAR T) therapy to treat adult cancer patients with certain blood cancers and lymphomas in the province.

“We are pleased to now offer this revolutionary CAR T therapy in Saskatchewan, so that patients no longer need to travel out of province to take advantage of this potentially lifesaving treatment,” Saskatchewan Cancer Agency President and CEO Deb Bulych said. “This exciting announcement would not be possible without the steadfast support from the Government of Saskatchewan, the Saskatchewan Health Authority and our health system partners.”

Click here to read more